Trials / Completed
CompletedNCT01453244
Pharmacogenomic Research in Korean Patients With Hepatitis C
Pharmacogenomic Research for Prediction of Drug Response in Korean Patients With Hepatitis C
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 373 (actual)
- Sponsor
- Inje University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the relationships between drug response and the host genetic factors, viral factors and clinical factors in chronic hepatitis C patients (HCV). And thus, the investigators are trying to develop the pharmacogenomic guideline in the Korean patients with HCV.
Conditions
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2011-10-17
- Last updated
- 2013-06-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01453244. Inclusion in this directory is not an endorsement.